1887

Abstract

Purpose. In this study, we differentiated between tuberculosis (TB) and infections caused by nontuberculous mycobacteria (NTM) or Nocardia in a tertiary general hospital in China. Differences in clinical manifestations and factors between respiratory infections associated with these organisms were also investigated.

Methodology. A retrospective analysis was conducted for suspected pulmonary TB patients with positive bacterial culture results under treatment at Wangjing Hospital, a tertiary general hospital, between January 2014 and June 2017. Sputum samples were submitted for liquid culture and species identification by mass spectrometry.

Results. Between January 2014 and June 2017, a total of 3981 suspected TB cases were analysed, of which 151 (3.8 %) exhibited positive mycobacterial culture results. Using mass spectrometry, the 151 isolates were classified into three groups: Mycobacterium tuberculosis (MTB) (n=112; 74.2 %), NTM (n=21 13.9 %) and Nocardia (n=18; 11.9 %). The NTM and Nocardia prevalence rates were significantly higher amongst elderly patients [aged ≥65 years; odds ratio (95 % confidence interval): 3.89 (1.05–14.38) for NTM; odds ratio (95 % confidence interval): 5.10 (1.09–23.91) for Nocardia ]. In addition, treatment with immunosuppressive therapy [odds ratio (95 % confidence interval): 3.92 (1.16–13.27)] was identified as a risk factor for Nocardia infection in these patients.

Conclusion. Our results demonstrated that a quarter of culture-positive ‘suspected TB patients’ harboured NTM or Nocardia infections. Notably, nearly all patients with non-TB infections presented with clinical syndromes mimicking pulmonary TB. Individuals receiving immunosuppressive therapy were at greater risk of acquiring Nocardia infections.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000961
2019-04-25
2019-12-06
Loading full text...

Full text loading...

References

  1. World Health Oragnization Global Tuberculosis Report 2017 Geneva, Switherland: World Health organization; 2017;43
    [Google Scholar]
  2. Wang L, Zhang H, Ruan Y, Chin DP, Xia Y et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet 2014;383:2057–2064 [CrossRef]
    [Google Scholar]
  3. Wang L, Liu X, Huang F, Hennig C, Uplekar M et al. Engaging hospitals to meet tuberculosis control targets in China: using the Internet as a tool to put policy into practice. Bull World Health Organ 2010;88:937–942 [CrossRef]
    [Google Scholar]
  4. Wang L, Cheng S, Xu M, Huang F, Xu W et al. Model collaboration between hospitals and public health system to improve tuberculosis control in China. Int J Tuberc Lung Dis 2009;13:1486–1492
    [Google Scholar]
  5. Wei X, Zou G, Walley J, Yin J, Lonnroth K et al. China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PLoS One 2014;9:e90596 [CrossRef]
    [Google Scholar]
  6. Gopinath K, Singh S. Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger?. PLoS Negl Trop Dis 2010;4:e615 [CrossRef]
    [Google Scholar]
  7. Hoza AS, Mfinanga SGS, Moser I, König B, Isolation KB. Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat?. BMC Infect Dis 2017;17:407 [CrossRef]
    [Google Scholar]
  8. Ministry of Health 2008; Notice about further strengthening of TB report and patient management Beijing: Disease Control Department;
    [Google Scholar]
  9. Xia H, Song YY, Zhao B, Kam K-M, O'Brien RJ et al. Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis 2013;17:107–112 [CrossRef]
    [Google Scholar]
  10. Tan Y, Li Q, Wang Q, Sun H, Chen J et al. Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China. Sci Rep 2017;7:3364 [CrossRef]
    [Google Scholar]
  11. Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 2016;54:376–384 [CrossRef]
    [Google Scholar]
  12. Raju RM, Raju SM, Zhao Y, Rubin EJ. Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease. Emerg Infect Dis 2016;22:365–369 [CrossRef]
    [Google Scholar]
  13. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977–982 [CrossRef]
    [Google Scholar]
  14. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013;42:1604–1613 [CrossRef]
    [Google Scholar]
  15. Pang Y, Tan Y, Chen J, Li Y, Zheng H et al. Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study. Eur Respir J 2017;49:1601429 [CrossRef]
    [Google Scholar]
  16. Wu J, Zhang Y, Li J, Lin S, Wang L et al. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study. PLoS One 2014;9:e109736 [CrossRef]
    [Google Scholar]
  17. Shao Y, Chen C, Song H, Li G, Liu Q et al. The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China. PLoS Negl Trop Dis 2015;9:e0003623 [CrossRef]
    [Google Scholar]
  18. Yu X, Liu P, Liu G, Zhao L, Hu Y et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect 2016;73:558–567 [CrossRef]
    [Google Scholar]
  19. Wang X, Li H, Jiang G, Zhao L, Ma Y et al. Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008-2011. Emerg Infect Dis 2014;20:1252–1253 [CrossRef]
    [Google Scholar]
  20. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009;49:e124–e129 [CrossRef]
    [Google Scholar]
  21. Ali T, Chakraburtty A, Mahmood S, Bronze MS. Risk of nocardial infections with anti-tumor necrosis factor therapy. Am J Med Sci 2013;346:166–168 [CrossRef]
    [Google Scholar]
  22. Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003;48:3013–3022 [CrossRef]
    [Google Scholar]
  23. Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009;15:1556–1561 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000961
Loading
/content/journal/jmm/10.1099/jmm.0.000961
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error